Wave Life Sciences Ltd (NASDAQ: WVE) started the day on Thursday, with a price decrease of -0.79% at $6.30, before settling in for the price of $6.35 at the close. Taking a more long-term approach, WVE posted a 52-week range of $4.25-$16.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 607.85%. Meanwhile, its Annual Earning per share during the time was 34.27%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -43.09%. This publicly-traded company’s shares outstanding now amounts to $154.09 million, simultaneously with a float of $123.05 million. The organization now has a market capitalization sitting at $971.04 million. At the time of writing, stock’s 50-day Moving Average stood at $7.72, while the 200-day Moving Average is $9.94.
Wave Life Sciences Ltd (WVE) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Wave Life Sciences Ltd’s current insider ownership accounts for 20.16%, in contrast to 82.64% institutional ownership. According to the most recent insider trade that took place on Mar 20 ’25, this organization’s Director sold 10,500 shares at the rate of 9.77, making the entire transaction reach 102,574 in total value, affecting insider ownership by 16,115.
Wave Life Sciences Ltd (WVE) Earnings and Revenue Records
Wave Life Sciences Ltd’s EPS decrease for this current 12-month fiscal period is -43.09% and is forecasted to reach -1.03 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -1.87% through the next 5 years, which can be compared against the 34.27% growth it accomplished over the previous five years trading on the market.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Let’s observe the current performance indicators for Wave Life Sciences Ltd (WVE). It’s Quick Ratio in the last reported quarter now stands at 2.95. The Stock has managed to achieve an average true range (ATR) of 0.60. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.25.
In the same vein, WVE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.84, a figure that is expected to reach -0.26 in the next quarter, and analysts are predicting that it will be -1.03 at the market close of one year from today.
Technical Analysis of Wave Life Sciences Ltd (WVE)
If we take a close look at the recent performances of Wave Life Sciences Ltd (NASDAQ: WVE), its last 5-days Average volume was 1.33 million that shows progress from its year to date volume of 1.29 million. During the previous 9 days, stock’s Stochastic %D was recorded 26.74% While, its Average True Range was 0.57.
Raw Stochastic average of Wave Life Sciences Ltd (WVE) in the period of the previous 100 days is set at 11.81%, which indicates a major fall in contrast to 24.55% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 92.41% that was higher than 76.70% volatility it exhibited in the past 100-days period.
